Cargando…
ON01210.Na (Ex-RAD(®)) Mitigates Radiation Damage through Activation of the AKT Pathway
Development of radio-protective agents that are non-toxic is critical in light of ever increasing threats associated with proliferation of nuclear materials, terrorism and occupational risks associated with medical and space exploration. In this communication, we describe the discovery, characteriza...
Autores principales: | Kang, Anthony D., Cosenza, Stephen C., Bonagura, Marie, Manair, Manoj, Reddy, M. V. Ramana, Reddy, E. Premkumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3591351/ https://www.ncbi.nlm.nih.gov/pubmed/23505494 http://dx.doi.org/10.1371/journal.pone.0058355 |
Ejemplares similares
-
Administration of ON 01210.Na after exposure to ionizing radiation protects bone marrow cells by attenuating DNA damage response
por: Suman, Shubhankar, et al.
Publicado: (2012) -
Amelioration of radiation-induced hematopoietic and gastrointestinal damage by Ex-RAD(®) in mice
por: Ghosh, Sanchita P., et al.
Publicado: (2012) -
Rigosertib ameliorates the effects of oncogenic KRAS signaling in a murine model of myeloproliferative neoplasia
por: Baker, Stacey J., et al.
Publicado: (2019) -
Dual Inhibition of CDK4/Rb and PI3K/AKT/mTOR Pathways by ON123300 Induces Synthetic Lethality in Mantle Cell Lymphomas
por: Divakar, Saikrishna A., et al.
Publicado: (2015) -
Analysis of the metabolomic profile in serum of irradiated nonhuman primates treated with Ex-Rad, a radiation countermeasure
por: Li, Yaoxiang, et al.
Publicado: (2021)